Capital Advisors Ltd’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9K | Buy |
+158
| New | +$9K | ﹤0.01% | 809 |
|
|
2025
Q1 | – | Sell |
-11
| Closed | -$1K | – | 1352 |
|
|
2024
Q4 | $1K | Buy |
+11
| New | +$1K | ﹤0.01% | 1147 |
|
|
2024
Q2 | – | Sell |
-5
| Closed | – | – | 1391 |
|
|
2024
Q1 | $0 | Buy |
5
+1
| +25% | – | ﹤0.01% | 1364 |
|
|
2023
Q4 | $0 | Sell |
4
-1
| -20% | – | ﹤0.01% | 1301 |
|
|
2023
Q3 | $0 | Sell |
5
-2
| -29% | – | ﹤0.01% | 1294 |
|
|
2023
Q2 | $1K | Hold |
7
| – | – | ﹤0.01% | 1094 |
|
|
2023
Q1 | $1K | Hold |
7
| – | – | ﹤0.01% | 989 |
|
|
2022
Q4 | $1K | Sell |
7
-9
| -56% | -$1.29K | ﹤0.01% | 951 |
|
|
2022
Q3 | $1K | Buy |
+16
| New | +$1K | ﹤0.01% | 966 |
|
|
2022
Q1 | – | Sell |
-1
| Closed | – | – | 921 |
|
|
2021
Q4 | $0 | Buy |
+1
| New | – | ﹤0.01% | 819 |
|